« Logout | Web Universe | Contact Us |

About Cipralex Key publications For your patients Q & A Prescribing information

You are here:

Home » Key publications » Key publications within depression » Fast Onset of Action

Fast Onset of Action within depression

Escitalopram and suicidality in adult depression and anxiety

Pedersen et al., International Clinical Psychopharmacology 2005; 20: 139-143

Efficacy of escitalopram in patients with severe depression: a pooled analysis

Llorca, International Journal of Clinical Practice 2005; 59:268-275

Do equivalent doses of escitalopram and citalopram have similar efficacy: A pooled analysis of two positive placebo-controlled studies in major depressive disorder

Lepola et al., International Clinical Psychopharmacology 2004, 19:149-155

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

Montgomery et al., Neuropsychobiology 2004;50:57-64

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

Lepola et al., International Clinical Psychopharmacology 2003; 18:211-217

Escitalopram (S-enantiomer of Citalopram): clinical efficacy and onset of action predicted from a rat model

Montgomery et al., Pharmacology & Toxicology 2001;88:282-286

Last updated: 22.05.2006

Key publications

Key publications within depression

Superior Efficacy

Excellent Tolerability

Fast Onset of Action

Key publications within anxiety

Unique Serotonin Dual-Action

Key publications within Obsessive Compulsive Disorder (OCD)

Literature Search

PubMed
Google Scholar